• Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


Trading has been halted for ATLNE:SW

Snapshot for Actelion Ltd (ATLNE)

Open: - Day's Range: - Volume: 0
Previous Close: 65.26 52wk Range: - 1-Yr Rtn: -

Stock Chart for ATLNE

No chart data available.
  • 1M
  • 1Y
Interactive ATLNE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ATLNE

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SMI -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M CHF) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/16/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ATLNE

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for ATLNE

Actelion Ltd. is a pharmaceutical company that develops and markets synthetic small-molecule drugs against diseases related to the endothelium. The Company's drugs, Veletri and Tracleer, are used in the treatment of heart and pulmonary conditions.

Jean-Paul ClozelCEO/Co-FounderAndre C MullerChief Financial Officer
Otto SchwarzExec VP/COOGuy BraunsteinExec VP/Head:Clinical Dev
More Company Profile & Key Executives for ATLNE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil